Navigation Links
Array BioPharma to Present at the NewsMakers in the Biotech Industry Conference
Date:9/24/2013

BOULDER, Colo., Sept. 24, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the NewsMakers in the Biotech Industry Conference.  The public is welcome to participate in the conference through webcasts on the Array BioPharma website:  www.arraybiopharma.com.(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)Event:NewsMakers in the Biotech Industry ConferenceDate:Friday, September 27, 2013Time:10:30 a.m. Eastern Time Location:Millennium Broadway Hotel, New York, NYAbout Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company and currently expects significant progress toward generating data to support our upcoming Phase 3 / pivotal trial decisions.
Novartis began a Phase 3 trial evaluating Array-invented MEK162 in patients with NRAS-mutant melanoma in July 2013 and expects to begin a Phase 3 trial in patients with BRAF-mutant melanoma in 2013.  In addition, Array began a Phase 3 trial evaluating MEK162 in patients with low-grade serous ovarian cancer under the license agreement with Novartis in June 2013.  AstraZeneca began a pivotal trial with Array-invented selumetinib in patients with thyroid cancer in May 2013 and expects to begin a Phase 3 trial in patients with non-small cell lung cancer in 2013.  Two other wholly-owned drugs, ARRY-520 and ARRY-614, are also approaching Phase 3 or pivotal trial decisions which are expected by the end of 2013.  For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Tricia Haugeto
Array BioPharma Inc.
303-386-1193
thaugeto@arraybiopharma.com


'/>"/>
SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. New palm-sized microarray technique grows 1,200 individual cultures of microbes
2. DNA Microarray 2013 Market Report: A Focus on Sales Growth
3. Markets for PCR, DNA Microarray, DNA Sequencing, Mass Spectrometry and Flow Cytometry to Exceed $50 billion by 2015
4. IBNs Droplet Array sheds light on drug-resistant cancer stem cells
5. Alios BioPharma initiates Phase 1 clinical trial for respiratory syncytial virus infection
6. Exclusive agreement to distribute Affinity Biosensors Archimedes system extends Malvern Instruments biopharma solutions
7. New research on potential avocado health benefits presented at International Congress of Nutrition
8. Cytos Biotechnology Presents Additional Results From Phase 2a Study of CYT003 for the Treatment of Allergic Asthma
9. Yin-yang effect of sodium and chloride presents salt conundrum
10. Amgen Presents Pooled Analysis Showing AMG 145 Significantly Reduced LDL Cholesterol In Over 1,200 Patients
11. Efficacy of acupressure to relieve migraine nausea presented at International Headache Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2020)... ... June 08, 2020 , ... Cryo-Cell International’s announcement comes on ... workers in the medical field. The face masks will be distributed nationwide to ... every day to provide healthcare to pregnant women. The delivery of masks is ...
(Date:6/5/2020)... (PRWEB) , ... June 04, 2020 , ... “Although we ... health and well-being of our attendees, staff, and the public. We remain committed ... and safe ways to collaborate virtually,” said Julie Sutcliffe, President of WMIS. ...
(Date:5/30/2020)... ... 29, 2020 , ... eInfochips, a leading provider of product ... EchoNous Inc. to develop the cloud-based connected health KOSMOS platform that has been ... been clinically tested versus expert measurements, yielding improved results in precision and consistency. ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and monitoring ... did not take off as quickly as people initially expected, and where eSource is ... data electronically for clinical trials and then repurposing it for downstream analysis, at a ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
(Date:7/10/2020)... ... July 09, 2020 , ... In ... commonly used to suppress pigment formation in zebrafish embryos, maintaining optical transparency to ... by Dr MA has been using the zebrafish model to investigate the causes ...
(Date:7/1/2020)... ... June 29, 2020 , ... The Interlocal ... contracts to its membership, recently named BioFit Engineered Products an Awarded ... to purchase ergonomic seating, cafeteria tables, book trucks and carts at discounted pricing ...
Breaking Biology Technology: